doi: 10.3389/fimmu.2026.1774535 Received 24 December 2025 Revised 08 February 2026 Accepted 23 February 2026 Published 11 March 2026 Volume 17 - 2026 Edited by Francesco Ursini, Rizzoli Orthopedic Institute (IRCCS), Italy Reviewed by Aruljothi Muralidharan, United States Department of Veterans Affairs, United States Sukanya Vijayan, SRM University, India Updates Copyright 2026 Zhou, Li and Song
143 (eds Duarte, C
Ideal Candidates for GHK-Cu Therapy Adults aged 35+ experiencing age-related skin changes benefit most
138,139,140 These transport mechanisms, often coupled with vesicular trafficking and metabolic reprogramming, significantly reduce intracellular drug accumulation, attenuate target engagement and contribute to immune evasion, collectively undermining therapeutic efficacy
It should be noted that the amount of labeled amino acids (Cys+Met) in VP1 (7) is about one half of what it is in VP2 (14) or VP3 (17), therefore the VP1 band in the gel appears significantly lighter than the other two bands